Novel solid body forms of mesoprogestin 11beta-(4e-(hydroxyiminomethyl)-phen yl)-17alpha-methoxymethy - 17beta-methoxy-estra-4,9-dien-3-one

Details for Australian Patent Application No. 2001256344 (hide)

Owner Schering AG

Inventors Muller, Uwe; Hosel, Peter; Winter, Gabriele; Grawe, Detlef

Agent Davies Collison Cave

Pub. Number AU-B-2001256344

PCT Pub. Number WO01/90137

Priority 00110887 23.05.00 EP

Filing date 9 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 25 January 2007

International Classifications

A61K 31/569 (2006.01)

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 15/12 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

Event Publications

25 January 2007 Application Accepted

  Published as AU-B-2001256344

31 May 2007 Standard Patent Sealed

25 October 2007 Change of Name(s) of Applicant(s), Section 104

  Schering AG The name of the applicant has been changed to Bayer Schering Pharma Aktiengesellschaft

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001256345

2001256342